No description available.

No description available.

No description available.

No description available.

Gene transfer vectors based on the Agrobacterium tumefaciens Ti plasmid were used to develop a successful disarmed Agrobacterium tumefaciens-mediated transformation method for Lotus comiculatus. A binary vector construct, pJIT73, was used during the development of the Agrobacterium tumefaciens transformation system due to its selectable (Aph IV, nos- neo) and scorable markers. The effects of the antibiotics geneticin (G-418) and hygromycin B were studied. Use of kill curves and selection delay experiments allowed potentially suitable selection pressure parameters to be proposed. Using such selection during transformation experiments led to further optimisation of this stage of transformation. The influence of plant hormones on the regeneration of Lotus comiculatus explants was investigated and a modification of an established protocol using leaf explants was introduced as an attempt to reduce the overall time of regeneration. Various explants were used but leaf pieces were chosen as the most suitable explant on which to focus research. So, through alteration of various stages, including length of cocultivation and subsequent decontamination within the transformation process, a successful method was developed. Experiments indicated the optimum Agrobacterium tumefaciens strain to be used with Lotus comiculatus was the disarmed Ach5 type, LBA4404(pAL4404). Transgenic Lotus comiculatus plants were produced which expressed the scorable marker β-Glucuronidase gene (GUS) and the selectable marker for hygromycin B resistance, AphIV. Gene transfer was confirmed by Southern blotting. The new Agrobacterium tumefaciens-mediated vector system was used to introduce the cowpea trypsin inhibitor gene (CpTi) into Lotus comiculatus. However, although there was evidence for transformed callus development, no shoots were induced. By the use of previously established Agrobacterium rhizogenes-mediated system, an attempt was made to introduce the pea lectin gene (psl) into Lotus corniculatus. Hairy root regenerants were produced but genetic transfer was unconfirmed and attempted investigation of the plant - Rhizobium symbiosis involving Lotus corniculatus was not fulfilled.

Survival of engineered tissues in vivo requires the presence of an internal vascular network and immediate connection to the host vasculature. Modular tissue engineering approaches the vascularization ‘design’ requirement through fabrication of submillimeter-sized collagen microtissues (‘modules’) with endothelial cells (EC) seeded on the surface of the modules and functional or vascular support cells inside the modules. Several modules are then packed together to build a larger tissue. In this work, we explored biomaterial-based strategies to build vascularized modular tissue engineered constructs. A photocrosslinkable poloxamine-polylysine acrylate biomaterial was first synthesized to improve the mechanical limitations of collagen modules under flow, while still supporting EC attachment. An extracellular matrix (ECM)-based strategy was then explored to enhance the vascularization of the modules in vivo. Manipulation of the ECM was accomplished through lentiviral transduction of EC to overexpress Developmental endothelial locus-1 (Del-1), a pro-angiogenic ECM molecule. Supporting the hypothesis that Del-1 overexpression ‘tilts’ the balance in EC from a quiescent to a pro-angiogenic phenotype, human umbilical vein endothelial cells transduced to overexpress Del-1 (Del-1 HUVEC) formed more sprouts and had a distinct expression profile of angiogenic genes in vitro, relative to control eGFP HUVEC. While very few blood vessels formed upon subcutaneous injection of empty collagen modules coated with Del-1 or eGFP HUVEC in a SCID/Bg mouse model, embedding adipose derived mesenchymal stem cells (adMSC) inside the modules increased blood vessel formation. Moreover, Del-1 HUVEC and adMSC modules consistently had more blood vessels (donor-derived and total number of vessels) compared to eGFP HUVEC and adMSC, over the 21 day duration of the study, with the greatest difference observed at day 7 post-transplantation. In addition, more α-smooth muscle actin (SMA+) staining was observed in Del-1 implants compared to eGFP, suggestive of increased vessel maturation through recruitment of SMA+ pericytes and smooth muscle cells. Perfusion studies showed that the implant vasculature was connected to the host vascular network as early as day 7, and throughout the 21 day duration of the study, for both Del-1 and eGFP implants. Nevertheless, further normalization of the vasculature is likely required to improve perfusion at early time points after transplantation.

Survival of engineered tissues in vivo requires the presence of an internal vascular network and immediate connection to the host vasculature. Modular tissue engineering approaches the vascularization ‘design’ requirement through fabrication of submillimeter-sized collagen microtissues (‘modules’) with endothelial cells (EC) seeded on the surface of the modules and functional or vascular support cells inside the modules. Several modules are then packed together to build a larger tissue. In this work, we explored biomaterial-based strategies to build vascularized modular tissue engineered constructs. A photocrosslinkable poloxamine-polylysine acrylate biomaterial was first synthesized to improve the mechanical limitations of collagen modules under flow, while still supporting EC attachment. An extracellular matrix (ECM)-based strategy was then explored to enhance the vascularization of the modules in vivo. Manipulation of the ECM was accomplished through lentiviral transduction of EC to overexpress Developmental endothelial locus-1 (Del-1), a pro-angiogenic ECM molecule. Supporting the hypothesis that Del-1 overexpression ‘tilts’ the balance in EC from a quiescent to a pro-angiogenic phenotype, human umbilical vein endothelial cells transduced to overexpress Del-1 (Del-1 HUVEC) formed more sprouts and had a distinct expression profile of angiogenic genes in vitro, relative to control eGFP HUVEC. While very few blood vessels formed upon subcutaneous injection of empty collagen modules coated with Del-1 or eGFP HUVEC in a SCID/Bg mouse model, embedding adipose derived mesenchymal stem cells (adMSC) inside the modules increased blood vessel formation. Moreover, Del-1 HUVEC and adMSC modules consistently had more blood vessels (donor-derived and total number of vessels) compared to eGFP HUVEC and adMSC, over the 21 day duration of the study, with the greatest difference observed at day 7 post-transplantation. In addition, more α-smooth muscle actin (SMA+) staining was observed in Del-1 implants compared to eGFP, suggestive of increased vessel maturation through recruitment of SMA+ pericytes and smooth muscle cells. Perfusion studies showed that the implant vasculature was connected to the host vascular network as early as day 7, and throughout the 21 day duration of the study, for both Del-1 and eGFP implants. Nevertheless, further normalization of the vasculature is likely required to improve perfusion at early time points after transplantation.

A composite bioscaffold was constructed by encapsulating human decellularized adipose tissue (DAT) within a photopolymerized polysaccharide hydrogel towards the goal of forming an injectable scaffold for adipose tissue engineering. Methacrylated glycol chitosan (MGC) and methacrylated chondroitin sulphate (MCS) were investigated as the hydrogel base materials with varying DAT concentrations. Glycol chitosan and chondroitin sulphate were converted to photopolymerizable prepolymers through graft methacrylation using glycidyl methacrylate and methacrylate anhydride respectively to achieve a degree of substitution (DOS) of 15% and 16%, respectively. MGC and MCS gels containing 0, 3 and 5 w/v% cryo-milled DAT were fabricated and characterized by measuring sol content, equilibrium water content and compressive mechanical properties (n=4, n=3). An increase in stiffness and a decrease in sol and water contents were observed in the gels with higher DAT concentration, suggesting that the DAT was acting as a filler material that contributed to the crosslinking reaction. In vitro studies were conducted with primary human adipose-derived stem cells (ASCs) encapsulated in the DAT-polymer constructs to assess cellular viability (n=3, N=3) as well as adipogenic differentiation, quantitatively via glycerol-3-phosphate dehydrogenase (GPDH) enzyme activity (n=3, N=3) and qualitatively through end-point RT-PCR analysis of key adipogenic genes (LPL, PPARγ, and CEPBα) (n=2, N=3) and intracellular lipid staining (n=3, N=3). Incorporating the DAT with MGC or MCS hydrogels enhanced cell viability as compared to the MGC and MCS scaffolds alone, with the MCS + 5 w/v% DAT scaffold having the highest overall cell viability and total cell number. The addition of the DAT in the MGC and MCS scaffold groups enhanced ASC adipogenesis as measured by an increase in GPDH levels, adipogenic gene expression and intracellular lipid accumulation characteristic of adipocytes. The highest GPDH levels were observed in the induced MCS with 5 w/v% DAT scaffolds, as compared to all other scaffold groups and tissue culture controls. The GPDH activity in this group increased by almost three times between 3 and 14 days, consistent with the progression of differentiation. The results indicated that the MCS-based scaffolds incorporating the DAT promoted cell viability and adipogenesis, demonstrating great promise as composite scaffolds for soft tissue regeneration. / Thesis (Master, Chemical Engineering) -- Queen's University, 2011-12-23 15:12:37.772

Versican, a chondroitin sulfate proteoglycan, is one of the main components of the extracellular matrix and hence plays a central role in tissue morphogenesis and a number of pathologic processes. My main goal has been to investigate the mechanisms of versican gene regulation, focusing on the signal transduction pathways, promoter regions, cis-acting elements, and trans- factors. This thesis puts forth new knowledge regarding transcriptional regulation of the human versican gene. In chapter III, I present the cloning of a 752-bp fragment of the human versican promoter (- 634/+118 bp) and nine stepwise 5' deletion fragments in the PGL3-luciferase reporter plasmid. Furthermore, I identify three potential enhancer and two repressor regions in this promoter. I also demonstrate that both cAMP and C/EBPβ enhanced and repressed versican transcription in HeLa cells and rat aortic smooth muscle cells (SMC), respectively, suggesting that versican transcription is differentially regulated by the respective mediator and transcription factor in epithelial cells and SMC. In chapter IV, I reveal the role of PI3K/PKB/GSK-3β signaling pathway in regulating versican promoter activity and transcription. Furthermore, I identify that the β-catenin/TCF-4 transcription factor complex, one of the downstream targets of GSK-3β, mediates versican promoter activity and transcription. In chapter V, I identify that variations in C-terminal regions of TCF family members determine their repressor or enhancer properties on Wnt target genes. Furthermore, I show that curcumin is a strong inhibitor of the β-catenin/TCF-p300 mediated gene expression. In chapter VI, I demonstrate that the androgen receptor trans-activates versican transcription in prostate cancer cells. Furthermore, I show cross-talk between the androgen receptor and β-catenin in regulating versican transcription in prostate stromal fibroblasts. Overall, this study charts previously uncharacterized promoter elements, transcription factors, and signal transduction pathways involved in regulation of the versican gene.

Polycaprolactone (PCL) is a biodegradable synthetic polymer that is currently used in a number of biomedical applications. A number of concerns have been raised over the toxicity of initiators commonly employed for the synthesis of PCL. Therefore, more biocompatible initiators have been studied. The biocompatibility of PCL, itself, is adequate; however, improved bioactivity is desirable for several applications. Copolymerisation, and incorporation of bioactive fillers can both be used as ways of enhancing the bioactivity of PCL. Therefore, the global objective of this project was to enhance the bioactivity of PCL by copolymerisation of PCL with poly(ethylene glycol) (PEG) using a biocompatible calcium-based initiator. This calcium-initiator was expected to leave potentially bioactive calcium-initiator residues in the synthesised copolymers. A study of the ring-opening polymerisation of epsilon-caprolactone (CL) in the presence of a poly(ethylene glycol) (PEG) / calcium hydride (CaH2) co-initiation system was performed. Polymerisation kinetics were monitored by following the degree of conversion of CL by Fourier transform-Raman (FT-Raman) spectroscopy and 1H nuclear magnetic resonance spectroscopy (NMR). Resultant PCL-b-PEG-b-PCL (PCL/PEG/PCL) triblock copolymers were analysed by NMR and gel permeation chromatography (GPC). The observed rates of polymerisation for the synthesis of PCL/PEG/PCL triblock copolymers using the PEG / CaH2 co-initiator were much lower than expected. 1H NMR and Raman microspectroscopy analysis showed that the concentration of the active calcium-PEG alkoxide was much lower than the initial feed concentration of PEG. Even so, the molecular weight of PCL/PEG/PCL triblock copolymers could be predicted from the CL : PEG feed ratio. This was found to be due to a fast reversible transfer process. Inductively coupled plasma-atomic emission spectroscopy (ICP-AES) analysis of solutions containing acid digested, pure PCL/PEG/PCL copolymers showed calcium concentrations at equal to or greater than 77 % of the calcium feed concentration. These calcium-initiator residues were isolated and their structures confirmed by Fourier transform infrared-attenuated total reflectance spectroscopy (FTIR-ATR). They were found to be a mixture of calcium hydroxide (Ca(OH)2) and calcium carbonate (CaCO3). The effect of calcium-initiator residues on the in vitro mineralisation of PCL/PEG/PCL triblock copolymers, as well as the same effect on a model calcium-salt-doped PCL homopolymer system, was studied by immersion in simulated body fluid (SBF). In the model studied, PCL homopolymer was doped with low concentrations (0.2 - 2 w / w % Ca) of Ca(OH)2, or CaCO3. Results from the model study showed calcium phosphate (CaP) mineral deposition on Ca(OH)2-doped PCL, and not on CaCO3-doped PCL. This was attributed to the higher solubility of Ca(OH)2, compared to CaCO3. Minimal CaP deposition was observed on PCL/PEG/PCL triblock copolymers. This was attributed to the low Ca(OH)2 concentration in these samples. For all mineralised samples in the SBF studies, the formation of carbonated HAP was observed. Overall, the synthesis of PCL/PEG/PCL copolymers using the PEG / CaH2 co-initiator was found to be a suitable method for preparing reproducible materials. The calcium-based initiator was also found to have potential for increasing the bioactivity of PCL-based materials.